enGene Therapeutics' Dr. Richard Glickman resigned as director and chairman of the Board, effective July 15, 2026.
| IndividualDr. Richard Glickman | RoleDirector and Chairman of the Board | Type of ChangeResigned | Effective DateJuly 15, 2026 | ReasonResignation not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices | Replacement InfoNot disclosed | Background DetailsNot disclosed | Board/Committee Role ChangesResigned from membership of any committee of the Board |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.